Wilms tumor in a patient with 22q11.2 microdeletion

American Journal of Medical Genetics, Part A

Volumn 155, Issue 5, 2011, Pages 1162-1164

  Finch, Paul T ^a,b   Pivnick, Eniko K ^a   Furman, Wayne ^c   Odom, Christine C ^c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b LE BONHEUR CHILDREN S HOSPITAL   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

22q11.2 deletion; DiGeorge syndrome; VCFS; Wilms tumor

Indexed keywords

ANTINEOPLASTIC AGENT;

AORTA DISEASE; AORTA ROOT DILATATION; ARTICLE; CASE REPORT; CHILD; CHROMOSOME DELETION 22Q11; CHROMOSOME MICRODELETION 22Q11.2; COMPUTER ASSISTED TOMOGRAPHY; EAR INFECTION; EXTERNAL EAR MALFORMATION; FEEDING DISORDER; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HEMATURIA; HISTOPATHOLOGY; HUMAN; MALE; MICROARRAY ANALYSIS; NEPHRECTOMY; NEPHROBLASTOMA; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEINURIA; SPEECH DISORDER; TRANSTHORACIC ECHOCARDIOGRAPHY; VOMITING;

CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; HUMANS; MALE; WILMS TUMOR;

EID: 79955014650     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.33957     Document Type: Article

References (29)

1. Barbaux S, Niaudet P, Gubler MC, Grunfeld JP, Jaubert F, Kuttenn F, Fekete CN, Souleyreau-Therville N, Thibaud E, Fellous M, McElreavey K. 1997. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 17: 467-470.
2. Bassett AS, Chow EW, AbdelMalik P, Gheorghiu M, Husted J, Weksberg R. 2003. "The schizophrenia phenotype in 22q11 deletion syndrome". Am J Psychiatry 160: 1580-1586.
3. Beckwith JB. 1998. Nephrogenic rests and the pathogenesis of Wilms tumor: Developmental and clinical considerations. Am J Med Genet 79: 268-273.
4. Botto LD, May K, Fernhoff PM, Correa A, Coleman K, Rasmussen SA, Merritt RK, O'Leary LA, Wong LY, Elixson EM, Mahle WT, Campbell RM. 2003. A population-based study of the 22q11.2 deletion: Phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 112: 101-107.
5. Breslow N, Olshan A, Beckwith JB, Green DM. 1993. Epidemiology of Wilms tumor. Med Pediatr Oncol 21: 172-181.
6. Breslow NE, Olson J, Moksness J, Beckwith JB, Grundy P. 1996. Familial Wilms' tumor: A descriptive study. Med Pediatr Oncol 27: 398-403.
7. D'Antonio LL, Scherer NJ, Miller LL, Kalbfleisch JH, Bartley JA. 2001. Analysis of speech characteristics in children with velocardiofacial syndrome (VCFS) and children with phenotypic overlap without VCFS. Cleft Palate Craniofac J 38: 455-467.
8. Dome JS, Huff V. 2006. "Wilms Tumor Overview". GENEReviews 10 April 2006. 13 April 2010.
9. Eicher PS, McDonald-Mcginn DM, Fox CA, Driscoll DA, Emanuel BS, Zackai EH. 2000. Dysphagia in children with a 22q11.2 deletion: Unusual pattern found on modified barium swallow. J Pediatr 137: 158-164.
10. Fine SE, Weissman A, Gerdes M, Pinto-Martin J, Zackai EH, McDonald-McGinn DM, Emanuel BS. 2005. Autism spectrum disorders and symptoms in children with molecularly confirmed 22q11.2 deletion syndrome. J Autism Dev Disord 35: 461-470.
11. Green DM. 1985. Diagnosis and Management of Malignant Solid Tumors in Infants and Children. Boston: Martinus Nijhoffr Publishing.
12. Gripp KW, McDonald-McGinn DM, Driscoll DA, Reed LA, Emanuel BS, Zackai EH. 1997. Nasal dimple as part of the 22q11.2 deletion syndrome. Am J Med Genet 69: 290-292.
13. Gronskov K, Olsen JH, Sand A, Pedersen W, Carlsen N, Bak Jylling AM, Lyngbye T, Brondum-Nielsen K, Rosenberg T. 2001. Population-based risk estimates of Wilms tumor in sporadic aniridia. A comprehensive mutation screening procedure of PAX6 identifies 80% of mutations in aniridia. Hum Genet 109: 11-18.
14. Grundy P, Koufos A, Morgan K, Li FP, Meadows AT, Cavenee WK. 1988. Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11. Nature 336: 374-376.
15. Grundy P, Perlman E, Rosen NS, Warwick AB, Bender JG, Ehrlich P, Hoffer FA, Lee ND. 2005. Current issues in Wilms tumor management. Curr Probl Cancer 29: 221-260.
16. Huff V. 1998. Wilms tumor genetics. Am J Med Genet 79: 260-267.
17. John AS, McDonald-McGinn DM, Zackai EH, Goldmuntz E. 2009. Aortic root dilation in patients with 22q11.2 deletion syndrome. Am J Med Genet Part A 145A: 939-942.
18. Koesters R, Ridder R, Kopp-Schneider A, Betts D, Adams V, Niggli F, Briner J, von Knebel Doeberitz M. 1999. Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors. Cancer Res 59: 3880-3882.
19. McDonald-McGinn DM, Kirschner R, Goldmuntz E, Sullivan K, Eicher P, Gerdes M, Moss E, Solot C, Wang P, Jacobs I, Handler S, Knightly C, Heher K, Wilson M, Ming JE, Grace K, Driscoll D, Pasquariello P, Randall P, Larossa D, Emanuel BS, Zackai EH. 1999. The Philadelphia story: The 22q11.2 deletion: Report on 250 patients. Genet Couns 10: 11-24.
20. McDonald-McGinn DM, Tonnesen MK, Laufer-Cahana A, Finucane B, Driscoll DA, Emanuel BS, Zackai EH. 2001. Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: Cast a wide FISHing net! Genet Med 3: 23-29.
21. McDonald-McGinn DM, Reilly A, Wallren-Pettersoon C, Hoyme HE, Yang PY, Adam MP, Zackai EH, Sullivan KE. 2006. Malignancy in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Am J Med Genet Part A 140A: 906-909.
22. Metzger ML, Dome JS. 2005. Therapy for Wilm's tumor. Oncologist 10: 815-826.
23. Ping AJ, Reeve AE, Law DJ, Young MR, Boehnke M, Feinberg AP. 1989. Genetic linkage of Beckwith-Wiedemann syndrome to 11p15. Am J Hum Genet 44: 720-723.
24. Royer-Pokora B, Beier M, Henzler M, Alam R, Schumacher V, Weirich A, Huff V. 2004. Twenty-four new cases of WT1 germline mutations and review of the literature: Genotype/phenotype correlations for Wilms tumor development. Am J Med Genet Part A 127A: 249-257.
25. Scattone A, Caruso G, Marzullo A, Piscitelli D, Gentile M, Bonadonna L, Balducci G, Digilio MC, Jenkner A, Camassei FD, Boldrini R, Nazzaro P, Pollice L, Serio G. 2003. Neoplastic disease and deletion 22q11.2: A multicentric study and report of two cases. Pediatr Pathol Mol Med 22: 323-341.
26. Shprintzen RJ, Goldberg R, Golding-Kushner KJ, Marion RW. 1992. Late-Onset psychosis in the velo-cardio-facial syndrome. Am J Med Genet 42: 141-142.
27. Smith CA, Driscoll DA, Emanuel BS, McDonald-McGinn DM, Zackai EH, Sullivan KE. 1998. Increased prevalence of immunoglobulin A deficiency in patients with the chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Diagn Lab Immunol 5: 415-417.
28. Wieser R, Fritz B, Ullmann R, Muller I, Galhuber M, Storlazzi CT, Ramaswamy A, Christiansen H, Shimizu N, Rehder H. 2005. Novel rearrangement of chromosome band 22q11.2 causing microdeletion syndrome-like phenotype and rhabdoid tumor of the kidney. Hum Mutat 26: 78-83.
29. Wu HY, Rusnack SL, Bellah RD, Plachter N, McDonald-McGinn DM, Zackai EH, Canning DA. 2002. Genitourinary malformations in chromosome 22q11.2 deletion. J Urol 168: 2564-2565.